查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1146218

冷藏培养箱市场-增长、趋势、COVID-19 影响和预测 (2022-2027)

Refrigerated Incubators Market - Growth, Trends, and Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计冷藏培养箱市场在预测期内（2022 年至 2027 年）的复合年增长率为 5.6%。

COVID-19 带来了重大挑战，并将医疗和保健社区推向了极限。医院陷入困境是因为疾病的传播速度快于公司製造个人防护设备 (PPE) 和供应所需医疗用品的速度。但供应只是 COVID-19 给医疗器械行业带来的众多挑战之一。製冷行业是在抗击冠状病毒 (COVID-19) 大流行的幕后发挥关键作用的行业之一。从保持适当的温度，到药品的安全运输和储存，再到位于大厅和停车场等公共场所的传统医疗机构和急救医院中患者和护理人员的安全和舒适。我负责一切。药品需要严密的温度控制和监测，以符合行业法规和药品安全指南。儘管 COVID-19 造成了致命影响，但它对低温培养箱市场产生了重大的积极影响。

此外，在传染病研究活动中越来越多地采用冷藏培养箱，以及冷藏培养箱技术的不断进步是推动所研究市场增长的主要因素。日益严重的传染病威胁正在造成社会和经济风险。流行病和流行病占与医疗干预和传染病控制相关的医疗保健费用的大部分。例如，COVID-19 大流行已在世界各地造成重大生命损失，并对公共卫生、食品系统和工作场所构成前所未有的威胁。冷却培养箱的需求量越来越大，因为它们被旨在开发疫苗的研究人员用作工具。临床试验证实，来自Pfizer生物科技和Moderna的两款冠状病毒疫苗有效率超过90%。Pfizer的疫苗需要在-70°C下长期储存，而Moderna的疫苗需要在-20°C下长期储存。 （两者都可以在 2°C 至 8°C 的普通冰箱中短时间储存）。 Oxford/AstraZeneca 疫苗可以在普通冰箱环境中长期储存和运输。这些因素可能会推动冷藏培养箱的采用，并有助于所研究市场的增长。

还有一些技术特性，例如密码保护设置、开门警报、自动去污循环、自校准、预设警报、超温警报、即使在高温环境下也能实现安全和可重复孵化的恆温器。进步和最新趋势预计将在预测期内推动冷藏培养箱的销售。例如，Thermo Scientific 的新型冷藏培养箱采用强大的压缩机技术，非常适合需要高于、大约或低于正常实验室环境温度的热稳定性和均匀性的应用。旨在提供温度条件。

此外，市场主要参与者的新产品发布和战略活动对所研究市场的增长产生了积极影响。例如，2022 年 1 月，北美 PHC 公司推出了一款新型高性能台下式冷冻柜，旨在提供精确的温度控制和均匀性。 PF-L5181W-PA 符合 CDC（美国疾病控制与预防中心）指南，可将温度保持在 -15°C 至 -25°C 之间。无论该装置是满载还是空载，它都旨在保持 ±5°C 的严格均匀性，以存储关键疫苗和生物製品。此外，2019 年 1 月，Gilson 宣布推出一系列新的台式仪器，可提供样品混合、温度控制和离心功能。该仪器采用先进技术，可提高实验室生产力并节省宝贵时间。因此，由于产品发布和收购，预计该市场在预测期内将出现显着增长。

因此，由于上述因素，预计所研究的市场在分析期内将增长。然而，替代孵化器的可用性可能会阻碍市场增长。

主要市场趋势

51-200L 细分市场有望在预测期内实现显着的高增长

51-200L 冷藏培养箱是一款功能强大、高效的便携式装置，由内部风扇组成，可防止热分层并保持稳定的温度。此外，实时控制可以减少日常人工作业和设备的重复操作。 51-200L 低温培养箱经常用于微生物分析、细菌计数、高于和低于室温的生物样品培养以及促进老化研究。根据 Clinical Trials.gov 的一份报告，纽约干细胞基金会 (NYSCF) 将在 2021 年利用干细胞和其他类型的细胞来研究生物样本/样本，进行基因检测，并供将来使用。我们正在进行研究短期储存这些样本以研究各种状况和疾病。这些因素正在推动美国实验室采用冷藏培养箱。此外，根据在美国举行的第二届细胞与基因治疗国际会议，大学校园内有超过40,000个个体实验室参与生物学和生物医学领域的发展，仅此而已。因此，上述因素有望增加这些产品在目标人群中的采用率，并推动市场增长。

此外，市场主要参与者推出的产品对该细分市场的增长产生了积极影响。例如，2020 年 8 月，北美 PHC 公司发布了一款专为疫苗和生物製剂的存储而设计的新型高性能 MPR-S300H-PA-PA，其中精确的温度控制对于存储产品的安全至关重要。推出了 ECO 製药冰箱。因此，由于上述因素，预计 51-200L 细分市场在预测期内将出现显着增长。

冷藏培养箱市场有望由北美主导

由于传染病上升、人口老龄化和产品批准数量增加等因素，预计北美将主导市场。例如，根据美国联邦人口公报 (PBA) 的数据，美国 65 岁以上的人口数量将增加近一倍，从 2018 年的 5200 万增加到 2060 年的 9500 万，占总人口的 16%。预计增加到 23%。根据美国疾病控制和预防中心 2021 年 10 月发布的数据，老年人口更容易受到感染。总体而言，2019-2020 流感季报告了 3500 万例与流感相关的疾病、38 万例与流感相关的住院治疗、2 万例与流感相关的死亡以及 1600 万例与流感相关的医院就诊。这些是促进北美研究目标市场增长的关键因素。

关键产品的消息、市场参与者的高度集中或製造商在美国的存在是推动该国冷藏培养箱市场增长的一些因素。例如，2021 年 2 月，Middleby Corporation 的一个部门 Follett Products, LLC (Follett) 和 PHC Corporation of North America (PHCNA) 将提供超低温 (ULT) 冷冻机、医药级冷冻机，我们已经宣布了一项与 PHCbi 系列生物医学冰箱的销售合作。预计该地区持续的产品批准将推动市场的增长。因此，由于上述因素，预计北美地区的市场增长。

竞争格局

由于多家公司在全球和区域运营，因此冷藏培养箱市场本质上是分散的。竞争格局包括具有市场份额的知名国际公司和本地公司分析。 KG、Benchmark Scientific、Gilson, Inc. 等

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 在针对传染病的研究活动中更多地采用冷藏培养箱
    • 冷却培养箱技术进步的增加
  • 市场製约因素
    • 替代孵化器的可用性
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按类型
    • 小于 50L
    • 51-200 升
    • 201-750L
    • 751-1500 升
    • 1501L 或以上
  • 通过使用
    • 医院
    • 研究机构和学术机构
    • 製药公司、生物技术公司
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Binder GmbH
    • Thermo Fisher Scientific
    • PHC Holdings Corporation
    • Eppendorf AG
    • Amerex Instruments, Inc.
    • Sheldon Manufacturing, Inc.
    • LEEC Ltd.
    • Memmert GmbH+Co. KG
    • Benchmark Scientific
    • Gilson, Inc.

第七章市场机会与未来趋势

简介目录
Product Code: 91683

The refrigerated incubators market is expected to register a CAGR of 5.6% over the forecast period (2022-2027).

COVID-19 has greatly challenged the medical and healthcare communities and pushed them to the limits. Hospitals struggle as the disease spreads faster than the companies can produce Personal Protective Equipment (PPE) and supply the necessary medical supplies. But supply is just one of the many challenges that COVID-19 presents to the medical device industry. The cooling industry is one of the sectors that play a crucial part in the fight against the coronavirus (COVID-19) pandemic from behind the scenes. It takes care of everything from maintaining the proper temperature to safely transporting and storing medicines, as well as keeping patients and caregivers safe and comfortable in both traditional healthcare facilities and emergency hospitals set up in halls, parking lots, and other public spaces. Pharma products require close temperature control and monitoring to comply with industry regulations and pharmaceutical safety guidelines. Despite the deadly effect of COVID-19, there is a significant positive impact on the refrigerated incubators market.

Further, the rising adoption of refrigerated incubators for research activities targeting infectious diseases and the increasing technological advancements in refrigerated incubators are among the major factors driving the growth of the studied market. The rising threat of infectious diseases is responsible for creating social and economic risks. Epidemics and pandemics are responsible for a significant part of the healthcare costs associated with medical treatment and outbreak control. For example, the COVID-19 pandemic has resulted in a significant loss of human life around the world and poses an unprecedented threat to public health, food systems, and the workplace. The demand for refrigerated incubators is rising as they are used as tools by researchers who are trying to develop a vaccine. In clinical studies, two coronavirus vaccines - one from Pfizer-BioNTech and the other from Moderna - were found to be more than 90% effective. The Pfizer vaccine requires long-term storage at -70°C, while the Moderna vaccine required long-term storage at -20°C. (Both can be kept for a short time in a normal refrigerator at 2°C to 8°C.) The Oxford/AstraZeneca vaccine can be kept and carried for a long time at ordinary fridge settings. Such factors are likely to boost the adoption of refrigerated incubators, thereby contributing to the studied market growth.

Also, technological advancements and the latest trends in the refrigerated incubator market, such as password-protected settings, door opening alarms, auto decontamination cycles, self-calibration, pre-set alarms, over-temperature alarms, and thermostats, safe, reproducible incubation, and even at high ambient temperatures are expected to drive the sales of refrigerated incubators during the forecast period. For instance, the new Thermo Scientific refrigerated incubators utilize powerful compressor technology designed to provide optimal temperature conditions for applications that require thermal stability and uniformity above, around, or below the usual ambient laboratory temperature.

In addition, new product launches and strategic activities by major players in the market are positively affecting the growth of the market studied. For instance, in January 2022, PHC Corporation of North America introduced a new, high-performance undercounter freezer designed to provide precise temperature control and uniformity. The PF-L5181W-PA meets Centers for Disease Control and Prevention (CDC) guidelines and maintains temperatures between -15°C and -25°C. It has been engineered to maintain a tight uniformity of ±5°C for storing critical vaccines and biologics whether the unit is loaded or empty. Additionally, In January 2019, Gilson announced the launch of a new benchtop instrumentation product line offering mixing, temperature control, and centrifugation of samples. The instruments feature advanced technologies that improve lab productivity and save valuable time. Thus, owing to the product launches and acquisitions, the studied market is expected to have significant growth over the forecast period.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period. However, the availability of alternative incubators is likely to impede market growth.

Key Market Trends

51-200L Segment is Expected to Witness Significant High Growth Over the Forecast Period

51-200L refrigerated incubators comprise powerful and highly efficient portable units, consisting of an internal fan for preventing thermal layering and keeping a consistent temperature. Such incubators reduce daily manual tasks and repetitive operations on the instruments through real-time control. Frequent applications of 51-200L refrigerated incubators type involve microbiological analyses, determining germ count, biological specimen cultivation above and below room temperature and accelerating aging tests. According to the Clinical Trials.gov report, the New York Stem Cell Foundation (NYSCF) in 2021, conducts research, to study various conditions and diseases by utilising stem cells and other types of cells, conducting research on biological specimens/samples, performing genetic testing, and storing these samples for short periods of time for future use. Such factors highly support the adoption of refrigerated incubators in the United States laboratories. Further, according to the second international conference of cell and gene therapy in the US alone, there are more than 40,000 individual research laboratories located on university campuses involved in advancing the field of biological and biomedical sciences. Hence, owing to the above factors, the adoption of these products is likely to increase among the target population, driving market growth.

Furthermore, the product launches by major players in the market are positively affecting the growth of the segment. For instance, in August 2020 PHC Corporation of North America introduced a new, high-performance MPR-S300H-PA-PA ECO pharmaceutical refrigerator designed for vaccine and biologics storage where precise temperature control is essential for stored product safety. Therefore, the 51-200L segment is expected to witness significant growth over the forecast period due to the abovementioned factors.

North America is Expected to Dominate the Refrigerated Incubators Market

North America is expected to dominate the market owing to factors such as the growing number of infectious diseases, coupled with the rising geriatric population and the rising number of product approvals. For instance, according to the Bureau's Population Bulletin(PBA), the number of Americans 65 and older is expected to nearly double from 52 million in 2018 to 95 million by 2060, and the overall percentage of the population will increase from 16 percent to 23 percent. According to data published by the Centers for Disease Control and Prevention in October 2021, the geriatric population is more vulnerable to infectious diseases. Overall, 35 million flu-related illnesses, 380,000 flu-related hospitalizations, 20,000 flu-related deaths, and 16 million flu-related medical visits were reported in the 2019-2020 season. These are the key factors that contribute to the growth of the studied market in North America.

Key product news, high concentration of market players, or manufacturer's presence in the United States are some of the factors driving the growth of the refrigerated incubators market in the country. For instance, In February 2021 Follett Products, LLC (Follett), a division of The Middleby Corporation, and PHC Corporation of North America (PHCNA) have announced the formation of a partnership to market and sell the PHCbi line of ultra-low temperature (ULT) freezers, pharmaceutical grade refrigerators, and biomedical freezers to Follett's healthcare customers. These continuous product approvals in the region are anticipated to drive the growth of the market in the country. Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the North America Region.

Competitive Landscape

The refrigerated incubators market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known. include Binder GmbH, Thermo Fisher Scientific, PHC Holdings Corporation, Eppendorf AG, Amerex Instruments, Inc., Sheldon Manufacturing, Inc., LEEC Ltd., Memmert GmbH + Co. KG, Benchmark Scientific and Gilson, Inc., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising adoption of refrigerated incubators for research activities targeting infectious diseases
    • 4.2.2 Increasing technological advancements in refrigerated incubators
  • 4.3 Market Restraints
    • 4.3.1 Availability of alternative incubators
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Below 50L
    • 5.1.2 51-200L
    • 5.1.3 201-750L
    • 5.1.4 751-1500L
    • 5.1.5 Above 1501L
  • 5.2 By Application
    • 5.2.1 Hospitals
    • 5.2.2 Research Laboratories and Acedmic Institues
    • 5.2.3 Pharmaceutical and Biotechnology Companies
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Binder GmbH
    • 6.1.2 Thermo Fisher Scientific
    • 6.1.3 PHC Holdings Corporation
    • 6.1.4 Eppendorf AG
    • 6.1.5 Amerex Instruments, Inc.
    • 6.1.6 Sheldon Manufacturing, Inc.
    • 6.1.7 LEEC Ltd.
    • 6.1.8 Memmert GmbH + Co. KG
    • 6.1.9 Benchmark Scientific
    • 6.1.10 Gilson, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS